Call for Proposals HEALTH-2011-two-stage - Cooperation Programme HEALTH-2011-two-stage Closed!

Objectives

The general objetive of the FP7 Cooperation Work Programme in Health-2011 is to improve the health of European citizens and increasing the competitiveness and boost the innovative capacity of European health-related industries while businesses, and addres global health issues including emerging epidemics.

Actions

1.BIOTECHNOLOGY, GENERIC TOOLS AND MEDICAL TECHNOLOGIES FOR HUMAN HEALTH

1.1 HIGH-THROUGHPUT RESEARCH

  • HEALTH.2011.1.1-1: SME-targeted research for developing tools and technologies for high-throughput research
  • HEALTH.2011.1.1-2: Genome-based biomarkers for patient stratification and pharmacogenomic strategies

1.4 INNOVATIVE THERAPEUTIC APPROACHES AND INTERVENTIONS

  • HEALTH.2011.1.4-1: Regenerative medicine clinical trials
  • HEALTH.2011.1.4-2: Tools, technologies and devices for application in regenerative medicine.
  • HEALTH.2011.1.4-3: Development and production of new, high-affinity protein scaffolds for therapeutic use.

2. TRANSLATING RESEARCH FOR HUMAN HEALTH

2.1. INTEGRATING BIOLOGICAL DATA AND PROCESSES: LARGE-SCALE DATA GATHERING, SYSTEMS BIOLOGY

2.1.1 Large-scale data gathering

  • HEALTH.2011.2.1.1-2: Proteins and their interactions in health and disease.
  • HEALTH.2011.2.1.1-3: Large-scale genomics approaches to identify host determinants of infectious diseases.

2.2. RESEARCH ON THE BRAIN AND RELATED DISEASES, HUMAN DEVELOPMENT AND AGEING

2.2.1. Brain and brain-related diseases

  • HEALTH.2011.2.2.1-1: Investigatordriven clinical trials for childhood-onset neurodegenerative diseases.
  • HEALTH.2011.2.2.1-2: Understanding the role of neuroinflammation in neurodegenerative diseases.
  • HEALTH.2011.2.2.1-3: Addictive and/or compulsive behaviour in children and adolescents: translating pre-clinical results into therapies.

2.2.2. Human development and ageing

  • HEALTH.2011.2.2.2-1: Investigatordriven clinical trials for therapeutic interventions in elderly populations.
  • HEALTH.2011.2.2.2-2: Linking human development and ageing.

2.3. TRANSLATIONAL RESEARCH IN MAJOR INFECTIOUS DISEASES: TO CONFRONT MAJOR THREATS TO PUBLIC HEALTH

2.3.1. Anti-microbial drug resistance

  • HEALTH.2011.2.3.1-1: Investigatordriven clinical trials of off-patent antibiotics.
  • HEALTH.2011.2.3.1-4: Development of multi-analyte diagnostic tests.
  • HEALTH.2011.2.3.1-5: Development of tools to control microbial biofilms with relevance to clinical drug resistance.

2.3.3. Potentially new and re-emerging epidemics

  • HEALTH.2011.2.3.3-1: Identification of factors promoting the emergence of pathogens with human pandemic potential from pathogens with a zoonotic background and related prevention strategies.
  • HEALTH.2011.2.3.3-3: Development of an evidence-based behavioural and communication package to respond to major epidemic outbreaks.

2.4. TRANSLATIONAL RESEARCH IN OTHER MAJOR DISEASES

2.4.1. Cancer

  • HEALTH.2011.2.4.1-1: Investigatordriven treatment trials for rare cancers.
  • HEALTH.2011.2.4.1-2: Translational research on cancers with poor prognosis.


2.4.2. Cardiovascular diseases

  • HEALTH.2011.2.4.2-1: Investigatordriven clinical trials for the management of cardiovascular diseases.
  • HEALTH.2011.2.4.2-2: Evaluation and validation studies of clinically useful biomarkers in prevention and management of cardiovascular diseases.

2.4.3. Diabetes and obesity

  • HEALTH.2011.2.4.3-1: Investigatordriven clinical trials to reduce diabetes complications.
  • HEALTH.2011.2.4.3-2: Development of novel treatment strategies based on knowledge of cellular dysfunction.
  • HEALTH.2011.2.4.3-3: Molecular and physiological effects of lifestyle factors on diabetes/obesity.
  • HEALTH.2011.2.4.3-4: Genetic and environmental factors in obesity and/or diabetes in specific populations.

3. OPTIMISING THE DELIVERY OF HEALTHCARE TO EUROPEAN CITIZENS

3.3 HEALTH PROMOTION

  • HEALTH.2011.3.3-1: Developing methodologies to reduce inequities in the determinants of health.

 

European community funding

The Community provisional funding available for the call for proposals is:

  • 498,00 Million EUR (Annual budget for 2011)

All the important deadlines

  • 13 October 2010 - 9 years ago (Deadline for the presentation of proposals)

Further information about the call

Official webpage of the call

Useful documents

  • Work Programme 2011: COOPERATION - THEME 1 - Health (Work programme)
  • Call for Proposals HEALTH-2011-two-stage (Legal base)

Organisations eligible to participate

Opened to the following bodies or institutes with legal status established in the covered areas:

  • Any legal organisation

Covered areas

Bodies or institutes must have their registered legal seat in one of the countries taking part in the Programme which are:

  • European Union (EU)

Directorate-Generale responsible

Directorate-General for Research

Related calls for proposals

Related calls

Explore other programmes